Imatinib, which is also known as Glivec®, is a targeted therapy used to treat certain types of leukaemia and soft tissue sarcoma. It may also be used to treat other types of cancer as part of a research trial.
What is Imatinib?
Imatinib is a type of treatment called a tyrosine kinase inhibitor. Kinases are important proteins in the body that regulate how the cells grow and divide.
How imatinib works ?
Imatinib works by blocking (inhibiting) signals within the cancer cells that make them grow and divide. Blocking the signals causes the cells to die.